EDITORS-IN-CHIEF
Alan Phillips
ICON Clinical Research
UK
Email: Alan.Phillips@iconplc.com
John Scott
Silver Spring, MD
USA
Email: John.Scott@fda.hhs.gov
Jørgen Seldrup
jStatConsult
France
Email: jonse888@hotmail.com
ASSOCIATE EDITORS
Juan J. Abellan
GSK
UK
Christina Fletcher
Amgen Ltd.
UK
Daniel Fong
The University of Hong Kong
Hong Kong, China
Val Gebski
The University of Sydney
Australia
Ekkehard Glimm
Novartis
Switzerland
Lei Huang
Silver Spring, MD
USA
Meinhard Kieser
University of Heidelberg
Germany
Andreas Krause
Idorsia Pharmaceuticals Ltd
Switzerland
Heng Li
FDA
USA
Devan Mehrotra
Merck
USA
Tobias Mielke
QS Consulting
Germany
Karen Price
Eli Lilly and Co
USA
Bee Choo Tai
National University of Singapore
Singapore
Andrew Thomson
European Medicines Agency
UK
Yi Tsong
CDER, FDA
USA
SECTION EDITORS
Book Reviews
Feng Liu
AstraZeneca
USA
fenglpku2000@gmail.com
Teachers' Corner
Richard Kay
Independent Statistical Consultant
UK
Viewpoint
Christy Chuang-Stein
Chuang-Stein Consulting, LLC
USA
EDITORIAL ADVISORY BOARD
Simon Day
Clinical Trials Consulting & Training Ltd.
UK
Val Fedorov
ICON
USA
Andy Grieve
ICON
UK
Philip Hougaard
Lundbeck
Denmark
Steven Julious
University of Sheffield
UK
Oliver Keene
GlaxoSmithKline Research and Development
UK
Gary Koch
University of North Carolina
USA
Lisa LaVange
Silver Spring, MD
USA
Dennis Lendrem
Newcastle University
UK
Karl Lin
Silver Spring, MD
USA
Frank Rockhold
Duke University School of Medicine
USA
Kit C.B. Roes
University Medical Center Utrecht
Netherlands
Gerd Rosenkranz
Novartis Pharma AG
Switzerland
Barry Schwab
Johnson & Johnson
USA
Fred Snikeris
PAREXEL
USA
John W. Stevens
University of Sheffield
UK
Sue-Jane Wang
Silver Spring
USA